Tag Archives: NASDAQ:MASI

A Director at Masimo Corp is Exercising Options

Today it was reported that a Director at Masimo Corp (MASI – Research Report), Steven Barker, exercised options to buy 1,413 MASI shares at $137.95 a share, for a total transaction value of $194.9K. Following Steven Barker’s last MASI Buy

Analysts’ Top Healthcare Picks: Masimo Corp (MASI), Rhythm Pharmaceuticals Inc (RYTM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Masimo Corp (MASI – Research Report) and Rhythm Pharmaceuticals Inc (RYTM – Research Report) with bullish sentiments. Masimo Corp (MASI) Needham analyst

Needham Believes Masimo Corp (NASDAQ: MASI) Still Has Room to Grow

Needham analyst Michael Matson reiterated a Buy rating on Masimo Corp (MASI – Research Report) today and set a price target of $139. The company’s shares closed yesterday at $124.39, close to its 52-week high of $126.89. Matson observed: “We

The EVP & GC of Masimo Corp is Exercising Options

Today it was reported that the EVP & GC of Masimo Corp (MASI – Research Report), Thomas Samuel Mcclenahan, exercised options to buy 1,000 MASI shares at $22.40 a share, for a total transaction value of $22.4K. This recent transaction

Masimo Corp (MASI) Receives a Buy from Needham

Needham analyst Michael Matson reiterated a Buy rating on Masimo Corp (NASDAQ: MASI) today and set a price target of $139. The company’s shares closed yesterday at $115.60. Matson wrote: “MASI’s 3Q18 revenue and EPS beat consensus. Management raised its

Masimo Corp (MASI) Gets a Buy Rating from BTIG

In a report released yesterday, Sean Lavin from BTIG maintained a Buy rating on Masimo Corp (NASDAQ: MASI), with a price target of $130. The company’s shares closed yesterday at $115.60. Lavin noted: “As we previewed, Masimo posted a small